Skip to search formSkip to main contentSkip to account menu

LEPR gene

Known as: OBR, Leptin Receptor Gene, LEPR 
This gene plays a role in transcriptional regulation via activation of the STAT signal transduction pathway. The gene is also involved in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Es gilt Patienten mit sehr seltenen Formen der monogenen Adipositas zu identifizieren um ihnen eine optimierte oder bestenfalls… 
2014
2014
............................................................................................................................................... i Acknowledgements ....................................................................................................................... iii Table of contents ............................................................................................................................. v List of figures ................................................................................................................................ viii List of tables ..................................................................................................................................... xi List of abbreviations .................................................................................................................... xii Introduction ...................................................................................................................................... 1 1. The pulmonary circulation ........................................................................................................................ 2 2. Modulation of pulmonary vascular tone ............................................................................................. 3 2.1. External modulation by the sympathetic nervous system ................................................................. 4 2.2. Intrinsic modulation of the pulmonary vasculature .............................................................................. 6 3. Hypoxic pulmonary vasoconstriction ................................................................................................... 7 3.1. The role of pulmonary vascular smooth muscle ..................................................................................... 7 3.2. The role of pulmonary vascular endothelium ....................................................................................... 10 3.3. The role of the sympathetic nervous system ......................................................................................... 12 3.3.1. Regulation during acute hypoxia ...................................................................................................... 12 3.3.2. Regulation during chronic hypoxia .................................................................................................. 13 4. Pulmonary Hypertension ......................................................................................................................... 14 4.1. Epidemiology ....................................................................................................................................................... 15 4.2. Animal models for pulmonary hypertension. ........................................................................................ 16 4.2.1. Chronic hypoxia induced pulmonary hypertension ................................................................. 16 5. Obesity ............................................................................................................................................................. 18 5.1. Epidemiology of the obesity paradox ........................................................................................................ 18 5.2. Increased sympathetic nerve activity in obesity .................................................................................. 19 6. Synchrotron radiation microangiography ........................................................................................ 21 6.1. Uses of synchrotron radiation microangiography .............................................................................. 22 7. Summary ......................................................................................................................................................... 24 Objectives of this study .............................................................................................................. 25 1. Hypothesis ...................................................................................................................................................... 25 2. Aims ................................................................................................................................................................... 25 Methods ........................................................................................................................................... 26 1. Animals ............................................................................................................................................................ 26 vi 1.1. Inducing pulmonary hypertension ............................................................................................................. 26 1.2. Animals used in different protocols ........................................................................................................... 28 2. General surgical techniques .................................................................................................................... 29 2.1. Anaesthesia and surgical preparation ...................................................................................................... 29 2.2. Tracheotomy ........................................................................................................................................................ 29 2.3. Femoral artery and vein catheterisation ................................................................................................. 30 3. In vivo electrophysiology surgical preparation .............................................................................. 32 3.1. Left thoracotomy ................................................................................................................................................ 32 3.1.1. Isolating the stellate ganglion and pulmonary sympathetic nerve .................................... 33 3.2. In vivo electrophysiology experimental protocol ................................................................................ 35 3.3. In vivo electrophysiology data collection and analysis. ........................................................... 36 4. Microangiography ....................................................................................................................................... 38 4.1. Surgical preparation ......................................................................................................................................... 38 4.1.1. Right jugular vein catheterisation .................................................................................................... 38 4.2. Principles of synchrotron radiation microangiography ................................................................... 41 4.3. Positioning of the experimental rat ........................................................................................................... 41 4.4. Microangiography experimental protocol .............................................................................................. 44 4.4.1. Priming of the jugular catheter .......................................................................................................... 44 4.4.2. Baseline imaging ...................................................................................................................................... 44 4.4.3. Imaging during the acute hypoxia challenge ............................................................................... 45 4.4.4. Imaging after β1-­‐adrenoceptor blockade ...................................................................................... 45 4.4.5. Imaging after β1-­‐ and β2-­‐adrenoceptor blockade ..................................................................... 46 4.4.6. Terminating the protocol ..................................................................................................................... 46 4.5. Microangiography data acquisition. .......................................................................................................... 48 4.5.1. Heamodynamic data acquisition ....................................................................................................... 48 4.5.2. Image data acquisition ........................................................................................................................... 48 4.6. Microangiography data analysis ................................................................................................................. 49 4.6.1. Microangiography morphological analysis .................................................................................. 49 4.6.2. Microangiography haemodynamic data analysis ....................................................................... 49 4.6.3. Microangiography image enhancement ......................................................................................... 49 4.6.4. Microangiography image analysis .................................................................................................... 52 5. Equipment calibration .............................................................................................................................. 55 5.1. Blood pressure calibration ............................................................................................................................ 55 5.2. Nerve activity calibration ............................................................................................................................... 55 5.3. Microangiography scale calibration .......................................................................................................... 55 5.3.1. Reproducibility of microangiography vessel measurements ............................................... 55 6. Western blotting ........................... 
2012
2012
The adipocyte-derived hormone leptin plays an important role in regulation of energy homeostasis and the innate immune response… 
2011
2011
Th e objective of this study was detection of DNA polymorphism of the leptin receptor gene using the polymerase chain reaction… 
2009
2009
Objective To investigate the correlation between the polymorphism of leptin receptor gene Gln223Arg and type2 diabetes mellitus… 
2008
2008
The assay of genotypes of Gln223Arg variant (PCR-RFLP) in 692 subjects of Wuhan Han population with obesity and type 2 diabetes… 
2007
2007
Obesity is due to the combined effects of genes, environment, lifestyle, and the interactions of these factors. The adrenergic… 
2004
2004
Leptin receptor plays an important role in leptin functioning signal transduction and it may have direct effects on the… 
Review
2003
Review
2003
Type 2 diabetes is associated with a marked increase in cardiovascular disease. This review summarizes some of the experimental…